Novartis Receives Fda Breakthrough Therapy Designation For Rare Disease Med

Novartis Receives Fda Breakthrough Therapy Designation For Rare Disease Med

By, Admin 26 November 2021

Swiss Pharma Company Novartis Has Received A Breakthrough Therapy Designation (Btd) For Its Experimental Medication Iptacopan For The Rare Blood Disorder Paroxysmal Nocturnal Hemoglobinuria (Pnh).The Therapy, Also Known As Lnp023, Was Also Awarded A Rare Paediatric Disease Designation At The Same Time For The Treatment Of C3 Glomerulopathy (C3G), A Group Of Ultra Rare Conditions That Can Cause End-Stage Renal Disease.Iptacopan Is An Oral Factor B Inhibitor And Is In Development Not Only For Pnh And C3G, But Also A Number Of Other Renal Conditions With Complement System Involvement.This Includes Iga Nephropathy (Igan), Atypical Hemolytic Uremic Syndrome (Ahus), And Membranous Nephropathy (Mn).The Btd Designation Was Based On The Positive Interim Results From Two Ongoing Phase 2 Studies, Within Which Iptacopan Demonstrated Benefits In Patients Who Remained Anaemic And Dependent On Transfusions, Despite Standard Of Care Anti-Complement Treatment, As Well As Monotherapy In Anti-C5 Naive Pnh Patients.In This Study, Iptacopan Significantly Reduced Proteinuria

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!